News | Neuro Imaging | August 31, 2015

Results reveal difference between psychotics and control group through activity in region associated with information processing

psychotic patients, brain activity, movie viewing, fMRI, Alice in Wonderland, ECNP

August 31, 2015 — Researchers using functional magnetic resonance imaging (fMRI) have found that even first-episode psychotic patients process information differently from a control group. To ensure both groups experienced the same brain stimuli, the measurements were taken while the subjects watched a movie, Tim Burton's Alice in Wonderland. The work is being presented at the 28th European College of Neuropsychopharmacology (ECNP) conference in Amsterdam.

High-precision fMRI is often used in neuroscience to locate brain activity in response to stimuli. With psychotic patients, these experiments often look at chronically ill patients, and so the differences in brain activity shown in the scans would be more obvious than in most of real life. However, early psychosis is more difficult to detect: the patterns in the brain are not as 'hard wired' so the differences are more subtle when compared to control groups.

Given the subtle differences, researchers are also faced with the problem of trying to ensure the patients and controls receive the same stimuli while undergoing measurement, so that the brains of the patients and the controls are concentrating on the same things while being scanned. Ideally, these stimuli should be involving and information-rich, like in a real-life situation.

Now a group of Finnish researchers have come up with a creative solution: Patients and controls were scanned while watching the movie Alice in Wonderland, which guaranteed that they were receiving the same information-rich stimulus.

Using a 3-Tesla MRI device, they scanned the brains of 46 first-episode psychotic patients (meaning that they had only had one psychotic event) and 32 healthy controls, while watching the movie. The researchers found that significant differences could be seen in the precuneus region of the brain, which is an area associated with memory, visuospatial awareness, self-awareness and aspects of consciousness.

Lead researcher Eva Rikandi said: 'In this work, we attempted to determine whether a person is a first-episode psychosis patient or a healthy control subject just by looking at their brain activity recorded during movie viewing. We found, that by monitoring activity in a region known as the precuneus, we were able to distinguish patients from control subjects especially well. This would mean that the precuneus, a central hub for the integration of self- and episodic-memory-related information, plays an important role in this kind of information processing of psychotic patients.”

She continued: “We were able to achieve almost 80 percent classification accuracy using these methods. This is the first study which directly associates the beginnings of psychosis with the precuneus, so it is now important that much more research is done in this area'. The researchers hope that this approach can feed into earlier screening and better diagnosis of at-risk populations.”

ECNP President-Elect Prof. Celso Arango (Madrid) said, "The interesting question here is how patients with psychosis, even in their first episode, process information in a different way. Specifically how a movie such as Alice in Wonderland elicits the participation of different brain areas, and how that relates to the history of the person watching. What we would like to know is if patients with psychosis might see this as more or less relevant to their own life than would healthy controls. This movie is about a fantasy world, would it be different with other types of movie?"

For more information: www.ecnp-congress.eu


Related Content

News | Radiology Imaging

Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...

Time February 13, 2026
arrow
News | ARRS

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Time February 13, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 6, 2026 — A state-of-the-art intraoperative MRI (iMRI) has arrived at the University of Chicago Medicine, one of ...

Time February 06, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Stroke

Dec. 12, 2025 — Hyperfine, Inc. has announced that it has received FDA clearance for a new multi-direction diffusion ...

Time December 15, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
Subscribe Now